Report error Found 6 Enz. Inhib. hit(s) with all data for entry = 12305
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 2.33nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein kinase receptor UFO(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 2.36nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 2.5nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein kinase receptor UFO(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 5.36nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetTyrosine-protein kinase receptor UFO(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 6.30nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Centre National de la Recherche Scientifique
US Patent
Centre National de la Recherche Scientifique
US Patent
Affinity DataIC50: 48.2nMAssay Description:To calculate the IC50 inhibition of Axl and FLT3 by the compounds of the invention, 10 concentrations of each compound 1, 2 and 3 were prepared by 1/...More data for this Ligand-Target Pair
Ligand InfoSimilars


